#1Oct 3rd, 2007
After a January 2007 publication revealed DCA (dichloroacetae) had anti cancer properties in animal studies researchers in Canada have now started a phase 2 clinical trial after Health Canada gave approval, rather than a phase 1 study.

Unlike other national organizations like the NRC or the Canadian Breast Cancer Foundation, Health Canada is backing this non profitable drug, great job Health Canada! If only a national organization would help with funding a drug that doesn't make American pharmaceutical companies rich now.

DCA is cheap and not patentable, so major pharmaceutical companies will not fund studies. The researchers for this phase 2 study needed to get personal donations from the general public totalling 800K.

P.Fezziwig, contributor for Healthcare Reviews , -- , building a better healthcare system through patient feedback.